SCHEMBL22200344

SCHEMBL22200344

CC(C)n1c(=O)c(-c2cc(F)c(NSCCC(F)(F)F)c(F)c2)nc2cnc(N[C@H]3CC(F)CN(C(=O)OCc4ccccc4)C3)nc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 5/20 0.43
ALDH1A1 P00352 6/20 0.32
CYP1A2 P05177 6/20 0.32
CASP1 P29466 5/20 0.32
CASP7 P55210 5/20 0.32
HSD17B10 Q99714 5/20 0.32
CYP3A4 P08684 4/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CYP2C9 P11712 3/20 0.32
USP2 O75604 3/20 0.32
CYP2D6 P10635 2/20 0.32
HIF1A Q16665 2/20 0.32
CYP2C19 P33261 2/20 0.32
LMNA P02545 1/20 0.32
RECQL P46063 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
MAPK8 P45983 5/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357735 0.89 ERN1 (0.50) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL22200346 0.89 ERN1 (0.50) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL28644015 0.87 ERN1 (0.43) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL22200542 0.87 ERN1 (0.46) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL29356361 0.87 ERN1 (0.46) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL22200541 0.86 ERN1 (0.54) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL29357908 0.86 ERN1 (0.54) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL22200705 0.85 ERN1 (0.48) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL29356760 0.85 ERN1 (0.48) ERN1ALDH1A1CYP1A2CASP1CASP7
SCHEMBL22200342 0.81 ERN1 (0.63) ERN1ALDH1A1CYP1A2CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed